Jaguar Health files Series O Preferred Stock certificate for special dividend payable March 4

Jaguar Health, Inc.

Filed Certificate of Designation for 1,557,000 shares of Series O Convertible Preferred Stock.
Special dividend of 1/10th Series O share per common share + each of 2,400,765 eligible warrant shares; record date March 2.
Series O has no dividends, limited voting rights, liquidation preference $0.0001/share, and conversion at Minimum Price by Dec 31, 2026.
Transfer restricted without company consent; conversion limited to 19.99% beneficial ownership cap.
No trading market for Series O; optional conversion by company or automatic conversion on Dec 31, 2026.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Jaguar Health, Inc.: Filed Certificate of Designation for Series O Convertible Preferred Stock (effective 2026-03-02).

Change: charter amendment
Effective: 2026-03-02

Exact text from the filing

on March 2, 2026 the Company filed a Certificate of Designation of Preferences, Rights and Limitations of Series O Convertible Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, to designate 1,557,000 shares of the Company’s preferred stock, par value $0.0001 per share, as Series O Convertible Preferred Stock

View on SEC.gov

40 governance changes filed in the last 30 days. Browse all governance changes →

Jaguar Health, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-086882

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.